To explore how the loss of CDK5 altered the response of AML cells to AG636 we performed RNAseq in MOLM13 CDK5 knockout and control cells using a modified DRUG‐seq protocol (Ye et al, 2018). Here, CDK5 is linked to acute myeloid leukemia.